Scangarella-Oman NE, Hossain M, Perry CR, Tiffany C, et al. Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. Sex Transm Infect 2023;99:64-69.
PMID: 36411033